Amitell Capital Pte Ltd Sells 8,550 Shares of Tenet Healthcare Corporation $THC

Amitell Capital Pte Ltd reduced its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 16.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,592 shares of the company’s stock after selling 8,550 shares during the quarter. Tenet Healthcare accounts for 5.5% of Amitell Capital Pte Ltd’s portfolio, making the stock its largest position. Amitell Capital Pte Ltd owned about 0.05% of Tenet Healthcare worth $9,054,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in THC. William B. Walkup & Associates Inc. bought a new stake in Tenet Healthcare during the third quarter worth about $32,000. Westside Investment Management Inc. grew its position in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new stake in Tenet Healthcare during the 3rd quarter valued at $41,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the 2nd quarter valued at $35,000. Finally, True Wealth Design LLC grew its holdings in shares of Tenet Healthcare by 238.2% during the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after purchasing an additional 181 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $237.13 on Thursday. The company has a market capitalization of $20.62 billion, a P/E ratio of 15.31, a price-to-earnings-growth ratio of 1.16 and a beta of 1.44. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $240.83. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The company’s 50 day moving average price is $204.26 and its two-hundred day moving average price is $198.96.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently issued reports on THC shares. Raymond James Financial set a $245.00 price target on shares of Tenet Healthcare in a research report on Wednesday, October 29th. Truist Financial upped their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Guggenheim raised their price target on shares of Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a report on Friday, February 13th. Morgan Stanley reaffirmed an “overweight” rating and set a $260.00 price objective on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Barclays lifted their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.